Spyre Therapeutics, Inc.
SYRE News Today: Stay Updated with the Latest Spyre Therapeutics, Inc. News in Real Time
Find SYRE news now at Meyka AI. Stay informed with the latest Spyre Therapeutics, Inc. stocks updates, including price news, market analysis, and expert insights.
4259.T Stock Closes at ¥720 as ExaWizards Inc. Gains 0.42% on JPX
ExaWizards Inc. (4259.T) closed at ¥720 on JPX with +0.42% gain. Market cap ¥68.3B. AI stock analysis and trading data.
STRA Director Sells 666 Shares at $77.68 on May 06, 2026
Strategic Education director Thomas Waite sells 666 shares for $51,734. Insider trading activity on STRA stock May 2026.
ZTS Earnings Preview: Zoetis Q1 2026 on May 7
Zoetis earnings preview: Analysts expect $1.61 EPS and $2.30B revenue on May 7, 2026. Historical beat pattern suggests upside potential.
Bayer to acquire Perfuse Therapeutics in deal worth up to $2.45 billion
Bayer announced on May 6, 2026, that it will acquire Perfuse Therapeutics in a deal worth up to $2.45 billion. The move strengthens Bayer’s focus on eye care and new treatments for vision loss. Perfuse is known for its experimental drug PER-001, aimed at serious eye diseases. The deal shows how big pharma companies are…
EGLX.TO Surges 25% in Pre-Market Trading on May 6, 2026
EGLX.TO stock jumps 25% in pre-market session on May 6, 2026. Enthusiast Gaming Holdings Inc. trading at C$0.05 on TSX with volume surge.
COFORGE.NS Earnings Miss: EPS Down 1.68%, Revenue Slips
Coforge Limited missed Q1 2026 earnings estimates. EPS fell to $12.90 vs $13.12 expected, revenue hit $44.50B vs $44.63B forecast.
DDOG Earnings Preview: Datadog Q1 2026 on May 7
Datadog earnings preview: Analysts expect $0.50 EPS and $960.12M revenue on May 7, 2026. Historical beat pattern suggests upside potential.
CNQ.TO Stock Rises 0.79% Ahead of May 7 Earnings Report
CNQ.TO trades at C$65.26 with earnings announcement May 7. Meyka AI rates the stock B+ with a Buy recommendation.
COIN Coinbase Earnings Preview May 7, 2026
Coinbase earnings preview: Analysts expect $0.36 EPS and $1.51B revenue on May 7. Mixed historical performance signals caution.